Company
»
»
About Us
Our Core Values
Our History
Our Mission
Core Competency
Quality Management
Manufacturing Facilities
Research and Development
Corporate Social Responsibility
Therapeutic Areas
Investors
»
»
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Abridged Annual Report
Green Initiative
Public Notice
Products
»
»
API
»
»
EU
USA
Other Pharmerging Markets
Notice for C&E Program
Dosage Forms
»
»
EU
Rest of World
Product Query
Careers
»
»
Current Openings
Policies
»
»
»
BMW reports
»
»
Kalyani
BMW AR-2021 Kalyani
BMW Authorisation Kalyani
Baddi
BMW Authorization Baddi
BMW AR-2021 Baddi
CSR Policy
Vigil Mechanism Policy
Prevention of Sexual Harassment Policy
Appointment Nomination and Remuneration Policy
Contact
Search:
Investors
Investors
Board of Directors
Corporate Governance
Code of Conduct
Stock Info
Dividend History
Public Notice
Overall Expertise
Manufacturing Facilities
Research & Development
Corporate Governance
Annual Reports
» 2021-22
» 2020-21
» 2019-20
» 2018-19
» 2017-18
» 2016-17
Shareholders and Stock Information
» Annual General Meeting
14 AGM Notice
15 AGM Notice
16 AGM Notice
17 AGM Notice
18 AGM Notice
»
Details of unclaimed shares to be transferred to IEPF Authority
»
Details of unpaid dividend Transferred to IEPF
AGM 2013
AGM 2012
AGM 2011
Composition of CSR Committee
This is not hidden.
This is not hidden.
Top
© All Copyright Reserved | Fresenius Kabi Oncology Limited 2012
Data Protection
|
Imprint
|
Legal Disclaimer
|
Sitemap